£10.0M
The round was led by BGF with participation from Parkwalk, Cambridge Enterprise, and Cambridge Innovation Capital.
P
PredictImmune
PredictImmune develops prognostic tools for guiding treatment in immune-mediated diseases.
£10.0MTotal raised
PredictImmune develops pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases. The company offers products such as PredictSURE IBD to support personalised medicine.
Filed accounts
Shareholders' funds
Members only
Profit for the year
Members only
Employees
Members only
Cash, assets and headcount from PredictImmune's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
KS
Ken Smith
Head of the Department of Medicine